News

AZCERT's Scientific Review Committee has found substantial evidence that Opipramol (antidepressant), Revumenib (anticancer) and Sitafloxacin (antibiotic) are associated with the development of QT prolongation but lack convincing evidence of causing torsades de pointes (TdP). Therefore, these drugs have been added to the Possible Risk of TdP category (PR) and to the List of Drugs to Avoid in patients with Congenital Long QT Syndrome (DTA List).